Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 159

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes

Hadjadj, Jérôme, Aladjidi, Nathalie, Fernandes, Helder, Leverger, Guy, Magérus-Chatinet, Aude, Mazerolles, Fabienne, Stolzenberg, Marie-Claude, Jacques, Sidonie, Picard, Capucine, Rosain, Jérémie, Fourrage, Cécile, Hanein, Sylvain, Zarhrate, Mohammed, Pasquet, Marlène, Abou Chahla, Wadih, Barlogis, Vincent, Bertrand, Yves, Pellier, Isabelle, Colomb Bottollier, Elodie, Fouyssac, Fanny, Blouin, Pascale, Thomas, Caroline, Cheikh, Nathalie, Dore, Eric, Pondarre, Corinne, Plantaz, Dominique, Jeziorski, Eric, Millot, Frédéric, Garcelon, Nicolas, Ducassou, Stéphane, Perel, Yves, Leblanc, Thierry, Neven, Bénédicte, Fischer, Alain, Rieux-Laucat, Frédéric · 2019 · Blood

Abstract

Evans syndrome (ES) is a rare severe autoimmune disorder characterized by the combination of autoimmune hemolytic anemia and immune thrombocytopenia. In most cases, the underlying cause is unknown. We sought to identify genetic defects in pediatric ES (pES), based on a hypothesis of strong genetic determinism. In a national, prospective cohort of 203 patients with early-onset ES (median [range] age at last follow-up: 16.3 years ([1.2-41.0 years]) initiated in 2004, 80 nonselected consecutive individuals underwent genetic testing. The clinical data were analyzed as a function of the genetic findings. Fifty-two patients (65%) received a genetic diagnosis (the M+ group): 49 carried germline mutations and 3 carried somatic variants. Thirty-two (40%) had pathogenic mutations in 1 of 9 genes known to be involved in primary immunodeficiencies (TNFRSF6, CTLA4, STAT3, PIK3CD, CBL, ADAR1, LRBA, RAG1, and KRAS), whereas 20 patients (25%) carried probable pathogenic variants in 16 genes that had not previously been reported in the context of autoimmune disease. Lastly, no genetic abnormalities were found in the remaining 28 patients (35%, the M− group). The M+ group displayed more severe disease than the M− group, with a greater frequency of additional immunopathologic manifestations and a greater median number of lines of treatment. Six patients (all from the M+ group) died during the study. In conclusion, pES was potentially genetically determined in at least 65% of cases. Systematic, wide-ranging genetic screening should be offered in pES; the genetic findings have prognostic significance and may guide the choice of a targeted treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2018-11-887141

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 159

Metadata

Authors
Hadjadj, J., Aladjidi, N., Fernandes, H., Leverger, G., Magérus-Chatinet, A., Mazerolles, F., Stolzenberg, M.-C., Jacques, S., Picard, C., Rosain, J., Fourrage, C., Hanein, S., Zarhrate, M., Pasquet, M., Abou Chahla, W., Barlogis, V., Bertrand, Y., Pellier, I., Colomb Bottollier, E., Fouyssac, F., Blouin, P., Thomas, C., Cheikh, N., Dore, E., Pondarre, C., Plantaz, D., Jeziorski, E., Millot, F., Garcelon, N., Ducassou, S., Perel, Y., Leblanc, T., Neven, B., Fischer, A., & Rieux-Laucat, F.
Venue
Blood
Published
2019-07-04
Volume
134
Issue
1
Pages
9-21
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2927192868
Cited by
159
References
7
FWCI
6.49
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes. https://app.cochat.ai/papers/10.1182/blood-2018-11-887141
The paper
Hadjadj, J., Aladjidi, N., Fernandes, H., Leverger, G., Magérus-Chatinet, A., Mazerolles, F., Stolzenberg, M.-C., Jacques, S., Picard, C., Rosain, J., Fourrage, C., Hanein, S., Zarhrate, M., Pasquet, M., Abou Chahla, W., Barlogis, V., Bertrand, Y., Pellier, I., Colomb Bottollier, E., . . . Rieux-Laucat, F. (2019). Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes. Blood. https://doi.org/10.1182/blood-2018-11-887141

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.